• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.

作者信息

Haibel Hildrun, Rudwaleit Martin, Brandt Henning C, Grozdanovic Zarho, Listing Joachim, Kupper Hartmut, Braun Jürgen, Sieper Joachim

机构信息

Benjamin Franklin Hospital, Berlin, Germany.

出版信息

Arthritis Rheum. 2006 Feb;54(2):678-81. doi: 10.1002/art.21563.

DOI:10.1002/art.21563
PMID:16447247
Abstract
摘要

相似文献

1
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.阿达木单抗可减轻活动性强直性脊柱炎的脊柱症状：一项为期52周的开放标签试验的临床和磁共振成像结果
Arthritis Rheum. 2006 Feb;54(2):678-81. doi: 10.1002/art.21563.
2
Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.阿达木单抗可显著减轻强直性脊柱炎患者的脊柱和骶髂关节炎症：一项多中心、随机、双盲、安慰剂对照研究。
Arthritis Rheum. 2007 Dec;56(12):4005-14. doi: 10.1002/art.23044.
3
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.使用抗肿瘤坏死因子α单克隆抗体英夫利昔单抗成功治疗活动性强直性脊柱炎。
Arthritis Rheum. 2000 Jun;43(6):1346-52. doi: 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E.
4
Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.在一项为期 1 年的随访研究中，观察肿瘤坏死因子-α抑制剂治疗的中轴型脊柱关节炎患者的强直性脊柱炎疾病活动评分（ASDAS）和疾病活动的临床及 MRI 指标的反应性。
Ann Rheum Dis. 2010 Jun;69(6):1065-71. doi: 10.1136/ard.2009.111187. Epub 2009 Sep 9.
5
Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.定义加拿大脊柱关节炎研究联合会脊柱和骶髂关节磁共振成像指数用于强直性脊柱炎的最小重要变化。
J Rheumatol. 2012 Aug;39(8):1666-74. doi: 10.3899/jrheum.120131. Epub 2012 Jul 1.
6
MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.磁共振成像在预测强直性脊柱炎患者对抗肿瘤坏死因子治疗的主要临床反应中的应用
Ann Rheum Dis. 2008 Sep;67(9):1276-81. doi: 10.1136/ard.2007.073098. Epub 2007 Nov 15.
7
Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.低剂量英夫利昔单抗对强直性脊柱炎患者脊柱炎症的磁共振成像影响
J Rheumatol. 2010 Aug 1;37(8):1553-5. doi: 10.3899/jrheum.100422.
8
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.英夫利昔单抗联合甲氨蝶呤治疗活动性强直性脊柱炎：一项临床与影像学研究。
Ann Rheum Dis. 2005 Nov;64(11):1568-75. doi: 10.1136/ard.2004.022582. Epub 2005 Apr 13.
9
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.阿达木单抗可显著减轻活动性强直性脊柱炎的炎症和血清 DKK-1 水平，但会增加腰椎脂肪沉积。
Int J Rheum Dis. 2012 Aug;15(4):358-65. doi: 10.1111/j.1756-185X.2012.01734.x. Epub 2012 May 23.
10
Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.强直性脊柱炎和未分化脊柱关节炎患者在接受依那西普治疗期间脊柱和骶髂关节的磁共振成像
Ann Rheum Dis. 2005 Sep;64(9):1305-10. doi: 10.1136/ard.2004.032441. Epub 2005 Mar 18.

引用本文的文献

1
Anti-protein phosphatase magnesium-dependent 1A-IgM levels in patients with active ankylosing spondylitis: a potential biomarker.抗蛋白磷酸酶镁依赖性 1A-免疫球蛋白 M 水平在活动期强直性脊柱炎患者中的变化：一种潜在的生物标志物。
Adv Rheumatol. 2024 Sep 13;64(1):69. doi: 10.1186/s42358-024-00412-9.
2
Seronegative spondyloarthropathy-associated inflammatory bowel disease.血清阴性脊柱关节病相关的炎症性肠病。
World J Gastroenterol. 2023 Jan 21;29(3):450-468. doi: 10.3748/wjg.v29.i3.450.
3
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.
Filgotinib 可减少强直性脊柱炎的椎体和脊柱旁后炎症：来自 TORTUGA 试验的结果。
Rheumatology (Oxford). 2022 May 30;61(6):2388-2397. doi: 10.1093/rheumatology/keab758.
4
Influence of pregnancy/childbirth on long-term bone marrow edema and subchondral sclerosis of sacroiliac joints.妊娠/分娩对骶髂关节长期骨髓水肿和软骨下硬化的影响。
Skeletal Radiol. 2021 Aug;50(8):1617-1628. doi: 10.1007/s00256-020-03700-9. Epub 2021 Jan 21.
5
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.阿达木单抗生物类似药候选物（HS016）治疗活动性强直性脊柱炎在不同时间点的疗效指标变化
Front Pharmacol. 2020 Dec 7;11:606497. doi: 10.3389/fphar.2020.606497. eCollection 2020.
6
Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial.依那西普与阿达木单抗治疗强直性脊柱炎的头对头比较：一项开放标签随机对照交叉临床试验。
Front Med (Lausanne). 2020 Oct 30;7:566160. doi: 10.3389/fmed.2020.566160. eCollection 2020.
7
Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers.对于接受肿瘤坏死因子-α阻滞剂治疗的强直性脊柱炎患者，ASDAS临床反应的早期实现与计量学结果的长期改善相关。
Medicine (Baltimore). 2020 Oct 9;99(41):e22668. doi: 10.1097/MD.0000000000022668.
8
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.比较阿达木单抗（修美乐）和阿达木单抗生物类似药候选物（HS016）在中国活动性强直性脊柱炎患者中的疗效和安全性：一项多中心、随机、双盲、平行、III 期临床试验。
BioDrugs. 2020 Jun;34(3):381-393. doi: 10.1007/s40259-020-00408-z.
9
Canada-Denmark MRI scoring system of the spine in patients with axial spondyloarthritis: updated definitions, scoring rules and inter-reader reliability in a multiple reader setting.加拿大-丹麦脊柱关节炎磁共振成像评分系统：在多读者环境下更新的定义、评分规则和读者间可靠性。
RMD Open. 2019 Oct 13;5(2):e001057. doi: 10.1136/rmdopen-2019-001057. eCollection 2019.
10
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis.改良的施雷克强直性脊柱炎脊柱评分作为评估治疗对强直性脊柱炎结构进展影响的结局指标。
Rheumatology (Oxford). 2019 Mar 1;58(3):388-400. doi: 10.1093/rheumatology/key128.